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Abstract
Background: Periodontitis is a common oral inflammation, which is a risk factor for adverse pregnancy outcomes.
Intakes of vitamin D and calcium are inversely associated with occurrence and progression of periodontitis. This
study aims to assess the feasibility of a multi-component intervention, including provision of milk powder
supplemented with calcium and vitamin D and periodontal therapy (PT), for improving maternal periodontal health
and metabolic and inflammatory profiles of low-income Brazilian pregnant women with periodontitis.
Methods: The IMPROVE trial is a feasibility randomised controlled trial (RCT) with a 2 × 2 factorial design with a
parallel process evaluation. Pregnant women with periodontitis, aged 18–40 years and with < 20 gestational weeks
(n = 120) were recruited and randomly allocated into four groups: (1) fortified sachet (vitamin D and calcium) and
powdered milk plus PT during pregnancy, (2) placebo sachet and powdered milk plus PT during pregnancy, (3)
fortified sachet (vitamin D and calcium) and powdered milk plus PT after delivery and (4) placebo sachet and
powdered milk plus PT after delivery. Dentists and participants are blinded to fortification. Acceptability of study
design, recruitment strategy, random allocation, data collection procedures, recruitment rate, adherence and
attrition rate will be evaluated. Data on serum levels of vitamin D, calcium and inflammatory biomarkers; clinical
periodontal measurements; anthropometric measurements; and socio-demographic questionnaires are collected at
baseline, third trimester and 6–8 weeks postpartum. Qualitative data are collected using focus group, for analysis of
favourable factors and barriers related to study adherence.
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Discussion: Oral health and mineral/vitamin supplementation are much overlooked in the public prenatal
assistance in Brazil and of scarcity of clinical trials addressing these issues in low and middle-income countries,. To
fill this gap the present study was designed to assess the feasibility of a RCT on acceptability of a multi-component
intervention combining conventional periodontal treatment and consumption of milk fortified with calcium-vitamin
D for improving periodontal conditions and maternal metabolic and inflammation status, among Brazilian low-
income pregnant women with periodontitis. Thus, we hope that this relatively low-cost and safe multicomponent
intervention can help reduce inflammation, improve maternal periodontal health and metabolic profile and
consequently prevent negative gestational outcomes.
Trial registration: NCT, NCT03148483. Registered on May 11, 2017.
Keywords: Calcium, Feasibility randomised controlled trial, Milk, Pregnant women, Periodontal therapy, Vitamin D
Strengths and limitations of this study
 To the best of our knowledge, this is the first feasibility
trial to explore the acceptability of a multi-component
intervention combining milk powder supplemented
with calcium and vitamin D and periodontal therapy in
Brazilian pregnant women.
 This study will contribute to the limited literature
on the impact of milk intake, supplementation of
calcium and vitamin D and periodontal therapy for
improving maternal metabolic and inflammation
status and periodontal health.
 The evaluation process includes qualitative data to
support the assessment of barriers and facilitators
related to the study feasibility.
 Follow-up for this study is limited to 6–8 weeks after
birth due to study budget and timeframe. Ideally,
longer-term follow-up would be preferable to allow
for the initial effect of the intervention to be
assessed in both mothers and infants.
Background
Periodontitis is an inflammatory disease defined as a
bacterial gum infection causing a breakdown of soft tis-
sue and loss of tooth-supporting bone [1]. If untreated,
periodontitis can cause tooth loss potentially resulting
in low self-esteem, impaired speech and chewing and
reduced ability to eat healthy and nutritious food [2].
Periodontitis is one of the most common oral condi-
tions and is prevalent in both developed and developing
countries reaching approximately 20–50% of the global
population [3]. Pregnant women, due to hormonal
changes, are prone to develop periodontitis or existing
periodontitis may worsen with the progression of preg-
nancy [4]. In Brazil, the prevalence of moderate peri-
odontitis among pregnant women has been estimated
to be between 11% and 47% [5–8].
The inflammatory burden induced from periodontitis
may have repercussions beyond the oral cavity, leading to
low-grade systemic inflammatory status and metabolic
disturbances, which can affect the course of gestation [9].
Increased levels of pro-inflammatory mediators such as
interleukin-6 (IL-6), C-reactive protein (CRP) and matrix
metalloproteinase 9 (MMP-9) have been observed among
people with periodontitis [10–12].
Systematic reviews have shown that women with peri-
odontitis are at higher risk of delivering preterm (< 37
weeks gestation) and low-birth-weight (< 2.5 kg) babies,
[13–15] both of which are among the leading causes of
neonatal deaths [16]. The biological mechanism under-
lying the link between periodontitis and adverse pregnancy
outcomes is not fully known [17]. Periodontitis may cause
bacterial translocation through blood circulation or pro-
duction of inflammatory mediators associated with prema-
ture rupture of membranes and onset of delivery [18].
Additionally, it may initiate and propagate a framework for
insulin resistance and ultimately the manifestation of ges-
tational diabetes [9]. The vertical transmission of oral
pathogenesis is also a concern, as children of mothers with
periodontitis are at higher risk of acquiring periodontal
pathogens [19].
Randomised controlled trials (RCT) investigating
whether non-surgical periodontal therapy (PT) during
pregnancy has the potential of reducing miscarriage, pre-
term birth and low-birth-weight incidence have shown
conflicting results [20–23]. However, the majority of the
RCTs have found no significant effect [20, 22, 23], probably
due to the PT not being intense or early enough to prevent
disease progression, suggesting that ongoing periodontal
maintenance treatment throughout gestation might be
needed [24].
The active form of vitamin D has an important action
in relation to regulating calcium and skeletal homeosta-
sis and also acts as an anti-inflammatory and anti-micro-
bial agent that may be beneficial to periodontal health
by antibiotic effects on periodontopathogens and inhib-
ition of inflammatory mediators that contribute to the
periodontal destruction [25]. Besides vitamin D, calcium
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has also been associated with lower occurrence of peri-
odontitis, probably by prevention of alveolar bone loss
and better natural dentition, i.e. the higher calcium con-
sumption is associated with lower loss of tooth [26].
Calcium and vitamin D co-supplementation have been
hypothesised to act in synergy rather than independently
[27], since 1,25-dihydroxyvitamin D acts on the small intes-
tine and kidneys to increase absorption of calcium [25].
Previous studies in an adult Danish population have shown
that intakes of calcium within recommendations (1000 and
1200mg/day for men aged 51–70 and > 70 years, respect-
ively, and 1200mg/d for women aged ≥ 51 years) are associ-
ated with lower risk of periodontitis and tooth loss only
among those with higher intake of vitamin D (> 6.8 μg/d)
[28, 29]. These studies suggest that calcium obtained from
dairy sources was associated with benefits for periodontal
health. In addition, a non-randomised clinical trial per-
formed among Indian adults found that the group taking
vitamin D (250 IU/day) and calcium (500mg/day) supple-
mentation for 3months developed better periodontal
health (higher bone density and lower gingival bleeding
index) than the group that did not take supplementation
[30]. However, larger studies are needed to evaluate the ef-
fectiveness of this strategy in pregnant women.
In Brazil, the prevalence of vitamin D insufficiency
(defined as 25(OH) D levels < 20 ng/mL) in pregnant
women ranges from 16.1 to 43% [31, 32]. Moreover,
mean calcium consumption among adult Brazilian
women is only 476 mg/d [33], which is below the dietary
recommendations of 1000 mg/d [34].
Considering the high prevalence of periodontitis and
vitamin D insufficiency and low calcium consumption
among Brazilian pregnant women, the purpose of this
study is to assess the feasibility and acceptability of a
multi-component intervention, including provision of
milk powder supplemented with calcium and vitamin
D and periodontal therapy (PT), for improving mater-
nal periodontal health and metabolic and inflamma-
tory profiles.
Objectives
The primary and secondary objectives are described in
Table 1.
Methods/design
Study design and setting
The IMPROVE trial is a 2 × 2 factorial feasibility RCT
with a parallel process evaluation, i.e. the groups are not
cross-over [35], conducted among pregnant women with
an existing diagnosis of periodontitis. During recruitment,
participants are allocated to one of four intervention arms
using a permutated block randomisation matrix (Fig. 1).
The arms are as follows:
1) Semi-skimmed powdered milk fortified with
additional sachet of 500 mg calcium and 500 IU
vitamin D and early PT (PT during pregnancy)
2) Semi-skimmed powdered milk fortified with
additional sachet of 500 mg calcium and 500 IU
vitamin D and late onset PT (PT after delivery)
3) Semi-skimmed powdered milk with placebo sachet
and early PT
4) Semi-skimmed powdered milk with placebo sachet
and late onset PT
The 2 × 2 design allows gathering evidence to feed
into an adequately powered RCT to test two different
hypotheses, so the four arms will enable estimation of
the approximated effect that the specific combinations
of the intervention components add to improving con-
centrations of maternal blood metabolic/inflammation
markers and periodontal status.
Baseline data was collected up to second trimester
(T0), with follow-up at third trimester (T1) and 6–8
weeks postpartum (T2).
Questionnaire data
At the three points (T0–T2), the pregnant women with
periodontitis diagnosis answer questionnaires about sleep
[36], physical activity level [37], frequency of food con-
sumption [38], smoking habits, alcohol consumption,
maternal conditions (general questionnaire), pregnancy
complications, sunlight exposure, mental health [39],
health general [40] and social support [41]. At the base-
line, women also provided socioeconomic information. A
specific questionnaire on Oral Health Impact Profile
Table 1 Objectives of the IMPROVE feasibility trial
Primary Secondary
1. Feasibility of recruitment
strategy for local health service
and participants
1. Estimates of effect size and variability
to enable accurate sample size and
power calculations for a definitive RCT
2. Time necessary to recruit
participants
2. Identification of any differences
across age groups and other socio-
demographic factors with regards to
attrition rate
3. Acceptability of the study
design and random allocation
3. Identification of key barriers and
enablers to adoption, and large-scale
implementation, of the IMPROVE
trial are
4. What the most appropriate
inclusion/exclusion criteria are
4. Definition of required for
economic analysis and if they can
be collected reliably
5. Estimates of compliance,
satisfaction, follow- up and
attrition rates
5. The capacity of the research team
to embed this study into routine
practice in the Public Health Centres
6. To determine the initial effects of
the intervention, time and intervention-
time interaction on inflammatory
biomarkers concentrations and
periodontitis status
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PT = Periodontal Treatment; †Powdered milk and vitamin/ calcium or placebo sachets are delivered 
monthly. ‡The number of visits from dentist for periodontal treatment during pregnancy depends of 
STUDY PERIOD
Enrolment Prior-allocation Post-allocation Close-out
TIMEPOINT -t1
T0
Baseline
T1
Beginning of the 3o 
Trimester until 
delivery
T2
6-8 weeks 
postpartum
ENROLMENT:
Eligibility screen X
Informed consent X
Periodontitis diagnosis X
Allocation X
INTERVENTIONS:
Supplementation† +PT 
during pregancy‡
Placebo† +PT during 
pregancy‡
Supplementation† + 
postpartum PT‡
Placebo† + postpartum 
PT‡
ASSESSMENTS:
Socioeconomic 
assessment
X
Anthropometry X X X
Blood pressure X X X
Blood/Urine 
collection*
X X X
Questionnaires 
responses**
X X X
Periodontitis 
evaluation
X X
Focus group*** X
Baby blood collection 
(filter paper)****
severity of periodontitis. After discharge of dental treatment pregnant women will receive maintenance 
dental evaluation every two months. *Maternal blood levels of biomarkers of inflammation (C reactive 
protein, interleukin-6 and Matrix metallopeptidase 9); blood levels of 25-hydroxy vitamin D, glucose, 
insulin, calcium, parathyroid hormone, lipids (HDL, LDL and triglycerides) and urinary calcium and 
creatinine levels. **Oral health impact profile, smoking habits, alcohol consumption, maternal conditions, 
sleeping habits, pregnancy complications, solar exposure, mental health (depression), physical activity 
level, frequency of food consumption, general health and social support. ***Focus groups were also 
performed before recruitment among pregnant women who are cared for at the health centre in Duque de 
Caxias. ****Collected until 7 days postpartum (Baby vitamin D and calcium levels)
Fig. 1 SPIRIT flow diagram of the IMPROVE feasibility trial
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(OHIP) [42] was administered at baseline (T0) and 6–8
weeks postpartum (T2) (Fig. 1).
Biomarkers and measures
Anthropometric (height and weight) and blood pres-
sure are measured in T0–T2. Maternal blood samples
were collected in the morning after 12-h overnight fast
in the T0, T1 and after delivery (T2) for analysis of
biochemical markers. Also 24-h urine is collected at
three-time points (T0–T2) for analysis of urinary
calcium and creatinine. Prior to the urine collection,
all participants are carefully instructed regarding the
specific procedures. The blood and urine samples are
stored in a freezer with a temperature of − 80 °C until
analysis in the Institute of Nutrition Josué de Castro
at the Federal University of Rio de Janeiro.
Recruitment period and setting
The participant recruitment period started in April 2017
and ended in May 2018 with follow-up scheduled until
February 2019. The study is conducted in the Municipal
Health Centre of Duque de Caxias, Rio de Janeiro/Brazil.
This public health centre offers prenatal care for low-risk
pregnant women, child health programmes, as well as a
clinical laboratory. The population assisted by this centre is
of low income and most of them live in the surrounding
slums.
Duque de Caxias is a city in the metropolitan region
located geographically in the Rio de Janeiro state with
approximately 900,000 inhabitants [43]. Duque de
Caxias presents a neonatal mortality rate of 12.1 per
1000 live births, 0.7% of maternal deaths investigated
and 20.4% of families covered by the family health
strategy [44]. These programmes are targeted at fam-
ilies that live under adverse conditions and whose nu-
tritional status is impacted by multiple constraints
such as living with some degree of food insecurity
(limited access to adequate quantity and quality of
food) [45].
The latitude of Duque de Caxias is 22o 47′ S. This area
of Brazil is usually sunny all year round. The climate is
tropical and summers are hot and humid, while the winters
are mild and with more restricted rainfall. The pollution
index in this city is high according to the recommenda-
tions of the World Health Organization (mean annual con-
centrations of inhalable particles of diameter less than
10 μm< 20 μg/m3 [46], with a mean estimate of 45.9 (SD
21.6) μg/m3 between the years 2000–2008 [47].
Participants and eligibility criteria
The study population includes low-risk adult pregnant
women, with periodontitis, attending the prenatal care
in the Municipal Health Centre of Duque de Caxias, Rio
de Janeiro/Brazil. Inclusion and exclusion criteria are de-
scribed in Table 2.
Recruitment
In the first prenatal visit a member of the research team
introduced pregnant women to the study and invited
those initially interested in taking part to answer a pre-
liminary checklist for eligibility, except for the diagnostic
of periodontitis. After this, women were screened for
syphilis and HIV, as part of the routine pre-natal care.
Those who were preliminarily eligible and tested nega-
tive for syphilis and HIV were then invited to book a
dental examination. Those who screened positive for
periodontitis were provided with an informed consent
form and included in the study (Fig. 2).
Randomisation, allocation concealment and blinding
To avoid information bias, regarding influence of inter-
viewer by knowledge of group allocation of participants,
randomisation took place after baseline assessment. An
online randomisation system with a random mixture of
permuted block sizes, stratifying participants by current
smoking habit (yes vs. no) was provided and concealed
by Sealed Envelope Ltdtm.
Due to the nature of the intervention (early vs. late
PT), complete blinding of the intervention was not pos-
sible. However, dentists and participants were blinded to
group allocation regarding milk fortification. Outcome
assessment is blinded, and the dentist performing the
final periodontal examination is not aware of group allo-
cation regarding both placebo or fortified sachet and PT
before or after delivery.
Interventions
Participants were advised to take two servings of a pow-
dered vitamin D and calcium plus semi-skimmed milk
daily during breakfast and afternoon snack or supper to
avoid concomitant intake of the prenatal iron supple-
ments routinely prescribed for consumption with hot
main meals (e.g. lunch or dinner). Twenty grams (20 g)
of powdered semi-skimmed milk (of a commercial brand
available in Brazil) is mixed with a sachet (2 g), contain-
ing calcium (CAPOLAC 500mg) [48] and vitamin D3
(500 IU), to be reconstituted in 200 mL of potable water
for each serving or other preparations (i.e. to consume
with kneaded fruits, fruit smoothies, yogurt, porridge,
etc.). Sachets with vitamin D/calcium and milk powder
were provided monthly to participants in the fortified
group during routine prenatal visits.
In the first dental session, a full periodontal examin-
ation was repeated to allow comparison with the first
examination done during recruitment (screening) and
check the agreement between the two dentists. After
that, conventional non-surgical PT, consisting of
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prophylactic dental polishing to remove the sticky bac-
terial film that forms on the teeth overtime, scaling and
root planning, as necessary, was undertaken throughout
pregnancy, up to delivery (Fig. 1). The periodontal treat-
ment is carried out at the Municipal Health Centre of
Duque de Caxias. The treatment is performed by a
qualified and trained dentist who was not involved in
the screening procedure and was blind regarding group
allocation.
PT started right after the randomisation to ensure early
therapy initiation for the relevant treatment arms. The
number of treatment sessions depended on the severity of
the disease. However, participants were allowed up to five
treatment sessions. In each session, participants also re-
ceived personalised oral hygiene instructions. Standard
fluoride toothpaste, without any additional component
that could interfere in results, a toothbrush and dental
floss were provided to all participants. Monitoring sessions
(reassessment of dental conditions) were taken at
2-month interval. If necessary, PT and oral hygiene in-
structions were repeated.
All participants were advised not to alter their routine
physical activity throughout the study and not to con-
sume any supplements other than the ones provided by
the clinics. Throughout pregnancy, participants were
allowed to consume 400 μg/d folic acid and 60 mg/d
Table 2 Inclusion and exclusion criteria for the IMPROVE feasibility trial
Inclusion criteria Exclusion criteria
1. Aged ≥ 18 years at the time of recruitment 1. Positive diagnosis of HIV/AIDS, syphilis, psychosis, diabetes before pregnancy,
thyroid disease, or any disorder causing vitamin D hypersensitivity
(e.g. sarcoidosis and other lymphomatous disorders)
2. > 20 weeks gestation at first prenatal visit 2. Lactose intolerance, milk allergy, history of renal stones or family history of
renal stone and hyperparathyroidism
3. Positive diagnosis of periodontitis (≥ 1 tooth with at least one site
with ≥ 4 mm of clinical attachment loss (CAL) and presence of
bleeding on probing)
3. Extensive dental cavity (crowns of several teeth destroyed by caries) and
loss of tooth structure or use of fixed dental braces
4. Cognitively and physically able to complete an interview and oral
examination and willing to participate, including provision of blood
samples.
4. Use of antibiotics or any immune-suppressants or medication known to
affect vitamin D/calcium metabolism
5. Consumption of ≥ 4 servings/day of dairy products or taking vitamin D
supplements > 400 IU/day
Fig. 2 Recruitment of participants *Pregnant women with periodontitis but presenting extensive caries were excluded
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ferrous sulphate, as provided during standard prenatal
care in Brazil.
Control group
The control group are the women assigned to the
semi-skimmed powdered milk with non-fortified sachet
(placebo) with similar colour, flavour, smell and texture
as well as before and after dilution than fortified sachet,
during pregnancy and late onset PT (after delivery).
Late-onset PT starts after postpartum assessment, as
part of the routine dental care in the prenatal clinic. This
strategy is considered a more acceptable approach in
comparison to offering no PT intervention, since the
possibility of being assigned to an ‘untreated’ group
could limit recruitment and is more ethical.
All participants were informed about the benefits of
dairy food intake during pregnancy and given a brochure
to take home with general information about healthy
diet and oral health hygiene instructions once they en-
tered the study.
Dental examination
After initial screening, participants underwent a full
periodontal examination at baseline (T0) and postpar-
tum (T2). Periodontal examination was performed in full
mouth at six sites per tooth (known as mesiobuccal,
mid-buccal, distobuccal, mesiolingual, mid-lingual and
distolingual), using North Carolina periodontal probes,
dental mirror and gauze, but without X-rays. The model
chosen is justified because no partial record model pre-
sents reliability to replace full mouth examination [49].
The T0 and T2 evaluations take place in the recruitment
room, using a simple chair and a forehead flashlight.
Maintenance examinations are performed to assess the
periodontal status of those who had finished the treat-
ment during pregnancy, and these examinations are
done every 2 months. Data collection included gingival
bleeding on probing, probing depth, cementoenamel
junction-gingival margin distance (CAL) and dental mo-
bility. A tailored form was developed to register the data.
Oral examination and treatment procedures were per-
formed by calibrated and trained dentists. The dentists
always calibrated their probing force using a scale right
before the clinical examination. The recommended
probing force was approximately 20 g of pressure [50].
Process evaluation of qualitative data
Focus group discussions were held prior to trial recruit-
ment to discuss issues regarding recruitment strategy,
study design and data collection. In addition, group dis-
cussions were held throughout the study (second and
third trimester) to assess potential barriers and facilita-
tors to the intervention and data collection.
The process evaluation included qualitative data from
focus group and interviews [51, 52].
To perform a content analysis [53], the specific
process evaluation frame was developed including
two major categories: (1) dietetics abilities to under-
stand the way the women organise daily use of milk
sachet with their habitual food and (2) health care
and identification of their existing social support
network in health care. The evaluation frame was
used to generate content associated with two major
categories. Six themes were derived from two cat-
egories: (1) how to make and consume the food;
sharing of the food with other family members; and
(2) intolerances social support network and chal-
lenges in social life, access to health unit and identi-
fication of events related to pain and discomfort. All
researchers were trained to fill into a frame of
content previously structured with data related to
pregnant women’s speeches associated to the six
themes described above. Initially, one pilot focus
group was performed with five women of similar so-
cioeconomic conditions to those attending the health
clinic where the present study is taking place. After
some adjustments in the content of questions, the
data was coded into themes and classified into three
levels to identify favourable factors and health
events: favourable, not favourable and neutral.
Second focus group regarding the culinary knowledge,
health care practices including oral health and network
social support at Duque de Caxias territory was per-
formed prior to recruitment with 13 pregnant women
attending the health centre. Thus, in the present study,
we evaluated some of the barriers and enablers to par-
ticipation, recruitment and intervention delivery, as well
as the difficulties to go to the health unit.
Group discussions were held during the study after re-
cruitment to assess potential barriers and facilitators to
the intervention delivery and data collection. These
group discussions provided qualitative data about poten-
tial acceptability. Additionally, monthly individual meet-
ings were organised in the health centre with
participants throughout the study to complement and
update the qualitative data collection. Sentences and
phases were registered and added into the frame, and
frequency of occurrences, the patterns and the sequence
of data are analysed. These data were then used to assist
follow-up management and improve compliance with
the intervention (e.g. suggestions on how to overcome
reported barriers regarding milk consumption or monot-
onous diet). At the end of each participant’s involvement
in the study, they were asked to complete an anonymous
evaluation questionnaire to gain insights about women’s
participation experience, acceptability and compliance to
the study protocol.
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Adherence
Adherence were routinely assessed counting the unused
sachets monthly, i.e. number of returned sachet by preg-
nant women in their monthly visit. SMS reminders to
consume the sachets and milk were sent (once a week) to
participants to help prevent attrition. A surplus of plain
milk powder was provided to all women with young chil-
dren to ensure dose fidelity. Acceptance of the interven-
tion was evaluated via a questionnaire comprising
questions about quality of taste (both milk powder with
fortified and placebo sachet), possible difference in taste
between those provided by the study and the commercial
ones that they had tried. The amount of sachet consumed
and suggested time of consumption, as well as the con-
tinuation of the program were evaluated.
Moreover, in the focus group, the issues raised regard-
ing barriers to comply with the intervention protocol
were addressed (e.g. new recipes are provided to women
who complain about monotonous diet; possibility of
home delivery of the powdered milk and sachet, etc.).
A social media group in a free mobile app was created
to promote participant engagement and peer interaction.
This strategy may reduce the attrition rate and improve
the commitment with the project.
Outcome measures
Primary outcome measures
1) Feasibility (acceptability of study design,
recruitment strategy, random allocation and data
collection procedures).
Feasibility will be evaluated using mixed methods to
explore intervention delivery, participants’ acceptability,
challenges and issues faced during the study and recom-
mended changes to the study design. Moreover, the
number of protocol deviation; an estimate of the cost of
carrying out the study; time required for recruitment,
data collection, and analysis will be evaluated.
2) Recruitment rate
The total number of participants recruited into the
study, number of participants recruited per month,
number of invited women, and number of excluded par-
ticipants before and after the dental screening and rea-
sons for exclusion.
3) Adherence
Percentage of sachet consumed during the study per
group (based on the number of returned sachet by preg-
nant women in their monthly visit); average number of
follow-up visits, percentage of participants who provide
full data at baseline throughout pregnancy and up to 6–8
weeks postpartum.
4) Attrition rate
Number of dropouts in each study arm and reasons
for dropout.
Secondary outcome measures
1) Changes in mean and SD of percentage of sites with
bleeding on probing (BOP) and CAL between
postpartum and baseline
2) Changes in maternal blood levels of biomarkers of
inflammation (CRP, IL-6 and MMP-9)
3) Changes in maternal blood levels of 25(OH) D,
glucose, insulin, calcium, parathyroid hormone and
lipids (HDL, LDL and triglycerides)
4) Neonatal blood levels of 25(OH) D and calcium
Sample size
This is a feasibility study, and thus the final sample size
will be determined by the number of participants that
are feasible to recruit within the timescale and budget of
the project. For feasibility studies, a minimum of 12 sub-
jects per group is proposed by Julious [54], and a total
sample size of 70 subjects is proposed by Teare et al.
[55] for a continuous outcome. Since we are planning a
2 × 2 factorial RCT, a sample size of 120 (30 per group),
would be enough to detect a realistic event and allowing
for 58% dropout rates (considering a sample size of 70),
with sufficient precision and minimal bias for the esti-
mates, as well as the existence of an additive interaction
between the two interventions.
Patient and public involvement
Initially, we held meetings with directors and health
professionals at the centre to get details on the prenatal
care routine and logistics, socioeconomic and demo-
graphic profile of service users, numbers of pregnant
women attending per month, and whether the centre
offered free dental treatment and nutritional counsel-
ling for pregnant women. Subsequently, managers and
health professionals at the centre were consulted on
how to implement the project with minimal interfer-
ence in their routine practice. Also, informal consulta-
tions with female heath care users (n = 4) and pregnant
women (n = 15) attending the centre were performed to
know their opinion about the study, if they considered
it interesting for the population, if they had any sugges-
tions on how the project could be implemented, how
researchers could invite pregnant women to participate,
how the pregnant women would adhere to the pro-
posed protocol, if they would consume the milk and if
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they had any suggestion on how the team could help in
the maintenance of the consumption until the end of
the gestation. The views and suggestion of health care
professionals and service users were taken into consid-
eration during the implementation of the project.
Statistical analysis
Baseline characteristics of participants will be summarised
using descriptive statistics (i.e. means and standard devia-
tions for normally distributed continuous variables, me-
dians and ranges for skewed continuous variables,
frequencies and proportions for categorical/binary vari-
ables), for all four intervention arms and total sample. All
analyses will be according to the intention-to-treat ap-
proach, including all participants, regardless of adherence
to the study protocol. To determine the effects of the
intervention, time and group-time interaction on out-
comes (inflammatory biomarker concentrations and peri-
odontitis status), one-way repeated measures ANOVA will
be used. Intervention will be regarded as a between-sub-
ject factor and time with three-time points (T0, T1 and
T2) as a within-subject factor. Mean change of biomarker
concentrations, number of sites with bleeding on probing
and clinical attachment level (periodontal status) will be
compared between the four treatment groups using
ANCOVA, adjusted for their baseline values. A P value <
0.05 will be considered statiscally significant.
Data management
Questionnaires (quantitative data) are performed directly
using RedCap software (Research Electronic Data Cap-
ture), with features that minimises data entry errors and
facilitates conversion to other statistical software for data
analysis. Questionnaires were designed specifically so
that data entry in RedCap was made as accurate as
possible.
Questionnaires are peer reviewed before data entry to
search for missing data, erroneous values and inconsist-
ency. The identified problems are being solved (data
cleaning) using Stata 12 software (Stata Corp 12, TX,
USA). Quantitative data are being held in Stata data file
(.dta), which has the capacity to store hundreds of vari-
ables. Stata software is widely used in research and files
can be easily converted into other formats via Stata
transfer software. Qualitative interviews are being audio
recorded (with full participant consent) and stored in
MP3 files. Transcripts are analysed by thematic content
analysis and Nvivo software for supporting qualitative
analysis is used.
All laboratory specimens, evaluation forms, reports,
and other records are identified in a manner designed to
maintain participant confidentiality. All records are kept
in secure cabinets with limited access. Clinical informa-
tion cannot be released without the written permission
of the participant, except as necessary for monitoring
and auditing by the sponsor and regularity authorities.
The investigator and the study site staff involved in this
study are not allowed to disclose or use for any purpose
other than performance of the study.
Computers used to collate the data have limited access
measures via user names and passwords. Published re-
sults will not contain any personal data that could allow
the identification of individual participants. All confiden-
tial data (name, address, etc.) are archived separately
from research data. Data are housed on a secure server
protected by university firewalls and are subject to
backups.
Conditions for discontinuation of participation in this
clinical trial
1. If a pregnant woman withdraws consent for
participation in the clinical trial
2. If a participant is diagnosed after recruitment with
serious kidney disease, or other disease (i.e. lactose
intolerance, milk protein intolerance), which
vitamin D/calcium supplementation or milk
consumption are not recommended
Protocol amendments
The Ethics Committee will be informed if any amend-
ments of the protocol are planned, and these amend-
ments will only be implemented after approval.
Follow-up of adverse events
No risky procedure will be employed in this study, and
the proposed interventions are considered safe for both
the mother and the foetus. However, calcium supple-
mentation in pregnancy may cause constipation. To
circumvent this potential side effect, women are being
advised to drink enough fluids throughout the study.
Studies have shown that foetal excess of vitamin D me-
tabolites are unlikely to occur when maternal concentra-
tions are within a normal range [56]. Therefore, offering a
dose of 1000 IU vitamin D to women during pregnancy
would be unlikely to cause any toxicity effect. Recent stud-
ies have not identified adverse effects in pregnant women
and/or their children with the ingestion of vitamin D sup-
plementation above 1000 IU daily administered during
pregnancy [57–59]. Furthermore, the maximum tolerable
upper intake level of vitamin D in pregnant women is
4000 IU/day. This quantity of vitamin D a day to pregnant
women not only was associated with any toxicity but that
it also was associated with better birth outcomes, i.e. im-
provement in gestational age at birth [34].
In a Cochrane review, the authors concluded that vita-
min D supplementation, alone or in combination with
calcium and micronutrients, and the low side effect
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profile of vitamin D is a cost-effective measure and
favourable for use in under-resourced settings [60].
Regarding PT, it has been speculated whether periodontal
mechanical manipulation would cause bacteraemia, which
itself could initiate the pathway leading to adverse preg-
nancy outcomes [24]. However, a large RCT showed that
rates of adverse outcomes did not differ significantly be-
tween women who received treatments and those who did
not require treatment. Use of topical or local anaesthetics
during root planning was not associated with an increased
risk of experiencing adverse outcomes. The authors con-
cluded that essential dental treatment for moderate-to-se-
vere caries or fractured or abscessed teeth and periodontal
treatment are safe for pregnant women [61].
Venipuncture in newborns is impractical and collec-
tion of cord blood imposes a logistic burden to the hos-
pital staff. Alternatively, drops of neonatal capillary
blood will be collected via heel prick for measurement
of calcium and 25(OH) D concentrations at the routine
neonatal check-up. This test is harmless, with minimal
discomfort. The amount of blood taken is too small to
be likely to have any adverse effects.
Despite the minimal risks anticipated for this study,
any adverse event or serious adverse event will be de-
scribed according to its relatedness with the interven-
tions, for both the total sample and by treatment arms,
in the final study report.
Dissemination plan and impact
The main results of this study will be presented to
the director, participants, prenatal nurses and phys-
ician of the Municipal Health Centre of Duque de
Caxias, Rio de Janeiro/Brazil, through a workshop
given by the researchers. The results will also be pre-
sented at national and international conferences and
published in scientific journals in accordance with the
CONSORT statement [62] and its extensions relating
to non-pharmacological studies [63, 64] and TIDieR
(template for intervention description and replication)
[65] guidelines for intervention description and repli-
cation. Additionally, the results of this feasibility clin-
ical trial could inform the study design of a full RCT
in pregnant women with periodontitis.
Discussion
Periodontitis and vitamin D deficiency among pregnant
women have been highly associated with adverse
maternal-foetal outcomes including increased risk of de-
livering preterm and low-birth-weight newborns [13–15].
Despite the evidence on negative pregnancy outcomes,
the prevalence of periodontitis and maternal vitamin D
deficiency is still high in both developing countries and
developed countries.
There is no consensus between studies that evaluate
the association between PT alone during pregnancy with
improvements of periodontitis [20–23]. However, some
authors have observed that the occurrence of periodon-
titis is less frequent among adults consuming calcium
within recommendations and higher quantities of vita-
min D [28, 29] and that vitamin D and calcium co-sup-
plementation seems to improve metabolic profile of
pregnant women [27]. Moreover, there is limited but
suggestive evidence of positive association between milk
consumption and foetal growth and infant birthweight
in healthy Western populations [66].
Due to the fact that oral health and mineral/vitamin
supplementation are still overlooked in the prenatal
assistance in Brazilian and there is scarcity of clinical
trials addressing both oral health and calcium and
vitamin D deficiency, the present study was designed
for assessing the feasibility of a RCT on acceptability
of a multi-component intervention combining conven-
tional periodontal treatment and milk fortified with
calcium-vitamin D intake for improving periodontal
conditions and maternal metabolic and inflammation
status, among Brazilian low-income pregnant women
with periodontitis.
Policy makers, administrators and clinicians need to
take the necessary steps to eliminate this easily pre-
ventable threat to mothers and infants. Thus, we hope
that this relatively low-cost and safe multicomponent
intervention can help reduce inflammation and im-
prove maternal periodontal.
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